Xenotransplantation and pig endogenous retrovirusesMAGRE, Saema; TAKEUCHIL, Yasuhiro; BARTOSCH, Birke et al.Reviews in medical virology. 2003, Vol 13, Num 5, pp 311-329, issn 1052-9276, 19 p.Article

Hepatitis C virus-induced hepatocarcinogenesisBARTOSCH, Birke; THIMME, Robert; BLUM, Hubert E et al.Journal of hepatology. 2009, Vol 51, Num 4, pp 810-820, issn 0168-8278, 11 p.Article

Determinants of high titer in recombinant porcine endogenous retrovirusesHARRISON, Ian; TAKEUCHI, Yasuhiro; BARTOSCH, Birke et al.Journal of virology. 2004, Vol 78, Num 24, pp 13871-13879, issn 0022-538X, 9 p.Article

Evidence and consequence of porcine endogenous retrovirus recombinationBARTOSCH, Birke; STEFANIDIS, Dimitrios; MYERS, Richard et al.Journal of virology. 2004, Vol 78, Num 24, pp 13880-13890, issn 0022-538X, 11 p.Article

Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteinsSANDRIN, Virginie; BOULANGER, Pierre; PENIN, Francois et al.Journal of general virology. 2005, Vol 86, pp 3189-3199, issn 0022-1317, 11 p., 12Article

Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein E2 contribute to virus entryCALLENS, Nathalie; CICZORA, Yann; BARTOSCH, Birke et al.Journal of virology. 2005, Vol 79, Num 24, pp 15331-15341, issn 0022-538X, 11 p.Article

Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5α proteins including human TRIM5αWOOD, Andrew; WEBB, Benjamin L. J; BARTOSCH, Birke et al.Journal of general virology. 2009, Vol 90, pp 702-709, issn 0022-1317, 8 p., 3Article

Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimerCICZORA, Yann; CALLENS, Nathalie; MONTPELLIER, Claire et al.Journal of general virology. 2005, Vol 86, pp 2793-2798, issn 0022-1317, 6 p., 10Article

An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodiesBARTOSCH, Birke; VERNEY, Géraldine; DREUX, Marlène et al.Journal of virology. 2005, Vol 79, Num 13, pp 8217-8229, issn 0022-538X, 13 p.Article

Analysis of a highly flexible conformational immunogenic domain A in hepatitis C virus E2KECK, Zhen-Yong; LI, Ta-Kai; JINMING XIA et al.Journal of virology. 2005, Vol 79, Num 21, pp 13199-13208, issn 0022-538X, 10 p.Article

Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteinsGOLFARD, Anne; CALLENS, Nathalie; BARTOSCH, Birke et al.Journal of virology. 2005, Vol 79, Num 13, pp 8400-8409, issn 0022-538X, 10 p.Article

Vaccine-induced early control of hepatitis c virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicityROLLIER, Christine S; PARANHOS-BACCALA, Glaucia; STAIB, Caroline et al.Hepatology (Baltimore, Md.). 2007, Vol 45, Num 3, pp 602-613, issn 0270-9139, 12 p.Article

Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoproteinOWSIANKA, Ania; TARR, Alexander W; JUTTLA, Vicky S et al.Journal of virology. 2005, Vol 79, Num 17, pp 11095-11104, issn 0022-538X, 10 p.Article

Characterization of functional hepatitis C virus envelope glycoproteinsOP DE BEECK, Anne; VOISSET, Cécile; BARTOSCH, Birke et al.Journal of virology. 2004, Vol 78, Num 6, pp 2994-3002, issn 0022-538X, 9 p.Article

Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus PseudopartidesCOSSET, Francois-Loic; MARIANNEAU, Philippe; VERNEY, Geraldine et al.Journal of virology. 2009, Vol 83, Num 7, pp 3228-3237, issn 0022-538X, 10 p.Article

The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and InfectionBENEDICTO, Ignacio; MOLINA-JIMENEZ, Francisca; MAJANO, Pedro L et al.Journal of virology. 2009, Vol 83, Num 16, pp 8012-8020, issn 0022-538X, 9 p.Article

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitorsCHAPEL, Cynthia; GARCIA, Celine; DURANTEL, David et al.Journal of general virology. 2007, Vol 88, pp 1133-1143, issn 0022-1317, 11 p., 4Article

Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activitySCHOFIELD, Darren J; BARTOSCH, Birke; SHIMIZU, Yohko K et al.Hepatology (Baltimore, Md.). 2005, Vol 42, Num 5, pp 1055-1062, issn 0270-9139, 8 p.Article

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virusLAVILLETTE, Dimitri; TARR, Alexander W; VOISSET, Cécile et al.Hepatology (Baltimore, Md.). 2005, Vol 41, Num 2, pp 265-274, issn 0270-9139, 10 p.Article

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionLAVILLETTE, Dimitri; MORICE, Yoann; COSSET, Francois-Loic et al.Journal of virology. 2005, Vol 79, Num 10, pp 6023-6034, issn 0022-538X, 12 p.Article

Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteinsABRAHAM, Jean-Daniel; HIMOUDI, Nourredine; KIENY, Marie Paule et al.Vaccine. 2004, Vol 22, Num 29-30, pp 3917-3928, issn 0264-410X, 12 p.Article